Hemolytic uremic syndrome (HUS) is a common cause of acute
renal failure in infants, characterised by the triad of micro-angiopathic
hemolytic anaemia, thrombocytopenia, and acute renal insufficiency. Typical HUS
occurs after an episode of gastroenteritis caused by enterotoxigenic
Escherichia coli. HUS, on the other hand, is a side effect of invasive
pneumococcal infection. The lack of a clear laboratory procedure, inconsistent
case descriptions, unfamiliarity, a misdiagnosis of disseminated intravascular
coagulation (DIC), and cases of micro-angiopathic hemolytic anaemia and only
mild renal injury are all reasons for not diagnosing this disorder. The aim of
our research is to explain the epidemiology, treatment, and progression of HUS
in Tunisia following invasive pneumococcal infections. Between 2008 and 2016,
cases were discovered. A culture of cerebrospinal fluid, pleural fluid, or
blood was used to validate S. pneumoniae infection. We were able to include
eight children in the sample because they met our requirements. Fever,
respiratory symptoms, neurological signs, and unusual patterns were the most
common patterns. Pneumonia was a presenting feature in 6 of 8 cases (75%) and
two patients had pneumococcal meningitis verified. Positive yield for S. pneumoniae
by culture in pleural levy or discharge in two cases, cerebrospinal fluid in
two cases, and blood in four cases confirmed pneumococcal invasive infection.
The average length of stay in the hospital was 23.5 days. Many of the patients
were started on antibiotics. Six of the eight patients required dialysis for a
total of 27.8 days. Plasma exchange therapy was not used on any of the
patients. There were two patients who died. Following a lengthy stay in the
intensive care unit, one patient with pneumococcal pneumatocele developed
sepsis compounded by a nosocomial infection. One of the patients suffered from
bronchiectasis, which resulted in recurrent broncho-pulmonary infections. One
patient who was on dialysis at the time of discharge passed away four months
later.
Author (s) Details
Hammi Yousra
Department of Pediatric
Nephrology, Charles Nicolle Hospital, Tunis, Tunisia.
Sayari Taha
Department of Pediatric Nephrology, Charles Nicolle Hospital, Tunis,
Tunisia.
Chaffai Haifa
Department of Pediatric Nephrology, Charles Nicolle Hospital, Tunis,
Tunisia.
Borgi Aida
Pediatric intensive care unit of Béchir Hamza Hospital, Tunis, Tunisia.
Jallouli Manel
Department of Pediatric Nephrology, Charles Nicolle Hospital, Tunis,
Tunisia and Laboratory of research immunology of Renal Transplantation and
Immunopathology, Charles Nicolle Hospital, LR03SP01, Tunis El Manar University,
Tunis, Tunisia.
Abidi Kamel
Department of Pediatric Nephrology, Charles Nicolle Hospital, Tunis,
Tunisia and Laboratory of research immunology of Renal Transplantation and
Immunopathology, Charles Nicolle Hospital, LR03SP01, Tunis El Manar University,
Tunis, Tunisia.
Bouziri Asma
Pediatric intensive care unit of Béchir Hamza Hospital, Tunis, Tunisia.
Khaldi Ammar
Pediatric intensive care unit of Béchir Hamza Hospital, Tunis, Tunisia.
Gorgi Yousr
Laboratory of research immunology of Renal Transplantation and
Immunopathology, Charles Nicolle Hospital, LR03SP01, Tunis El Manar University,
Tunis, Tunisia.
Ben Abdallah Taieb
Laboratory of research immunology of Renal Transplantation and
Immunopathology, Charles Nicolle Hospital, LR03SP01, Tunis El Manar University,
Tunis, Tunisia.
Ben Jaballah Najla
Pediatric intensive care unit of Béchir Hamza Hospital, Tunis, Tunisia.
Gargah Tahar
Department of Pediatric Nephrology, Charles Nicolle Hospital, Tunis,
Tunisia and Laboratory of research immunology of Renal Transplantation and
Immunopathology, Charles Nicolle Hospital, LR03SP01, Tunis El Manar University,
Tunis, Tunisia.
View
Book :- https://stm.bookpi.org/HMMR-V6/article/view/632